IL-17 Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients.
about
Interleukin-17 Induces Expression of Chemokines and Cytokines in Prostatic Epithelial Cells but Does Not Stimulate Cell Growth In Vitro.Stromal cells induce Th17 during Helicobacter pylori infection and in the gastric tumor microenvironment.A subset of IL-17(+) mesenchymal stem cells possesses anti-Candida albicans effect.Inflammatory events during murine squamous cell carcinoma development.Interleukin-17 and type 17 helper T cells in cancer management and research.Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor.Senescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer.The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis.Anti-IL-17 therapy restricts and reverses late-term corneal allorejection.A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.IL-17-mediated M1/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws.The Identification of Macrophage-enriched Glycoproteins Using Glycoproteomics.A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It.
P2860
Q34269107-C35D0CD9-5D05-42E7-9F7A-8D62D11131B8Q34568217-0DD4B9A1-7B75-45D1-A9FC-40C8F6ABEBDAQ36522783-973B582A-AA1D-4EBD-9E04-BF0B3AD2130FQ36523752-B002DA12-F7CA-4AF0-86B6-E94FD35FE6DAQ37031654-4B802BD6-64F5-413C-8492-AB75EC938C61Q37046424-49200785-C20D-437C-BEC9-E45F4FBB269BQ38207592-9AB59440-6A28-4491-9E5F-54C31AF87311Q38238738-A6F56EC1-4F50-4493-870A-96ADFB8F33CFQ39414587-A3898D1D-3BA2-458A-995C-BBB43A704CDEQ39465087-94A918F1-8499-4761-A349-17DB2D3B996DQ41426868-92D78A96-39EA-4DC7-ABCA-23A13508A314Q46395675-0D8053EF-48CE-4F94-AC76-C64758BBCC4DQ54987441-D48C4AE3-774D-4889-A19D-2F5B136E8873
P2860
IL-17 Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
IL-17 Expression by macrophage ...... s in prostate cancer patients.
@en
type
label
IL-17 Expression by macrophage ...... s in prostate cancer patients.
@en
prefLabel
IL-17 Expression by macrophage ...... s in prostate cancer patients.
@en
P2093
P2860
P1476
IL-17 Expression by macrophage ...... s in prostate cancer patients.
@en
P2093
Eugene V Vykhovanets
Gregory T Maclennan
Olena V Vykhovanets
Sanjay Gupta
P2860
P304
P577
2011-08-03T00:00:00Z